Jim Simons Hookipa Pharma Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.59 - $1.04 $49,442 - $87,152	83,800 Added 38.36%	302,246 $178,000
Q1 2024 May 13, 2024	BUY	$0.61 - $0.83 $18,178 - $24,734	29,800 Added 15.8%	218,446 $156,000
Q4 2023 Feb 13, 2024	SELL	$0.42 - $0.86 $154,135 - $315,611	-366,990 Reduced 66.05%	188,646 $153,000
Q3 2023 Nov 14, 2023	SELL	$0.58 - $0.91 $205,436 - $322,322	-354,200 Reduced 38.93%	555,636 $342,000
Q2 2023 Aug 11, 2023	BUY	$0.71 - $1.97 $637,605 - $1.77 Million	898,036 Added 7610.47%	909,836 $801,000
Q1 2023 May 12, 2023	SELL	$0.72 - $1.03 $18,072 - $25,853	-25,100 Reduced 68.02%	11,800 $9,000
Q4 2022 Feb 13, 2023	SELL	$0.73 - $14.6 $76,869 - $1.54 Million	-105,300 Reduced 74.05%	36,900 $30,000
Q3 2022 Nov 14, 2022	BUY	$1.27 - $15.0 $60,325 - $712,500	47,500 Added 50.16%	142,200 $191,000
Q2 2022 Aug 12, 2022	BUY	$1.33 - $2.31 $125,951 - $218,757	94,700 New	94,700 $154,000
Q1 2022 May 13, 2022	SELL	$1.26 - $2.52 $494,928 - $989,856	-392,800 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.33 - $5.94 $915,224 - $2.33 Million	392,800 New	392,800 $915,000
Q3 2020 Nov 13, 2020	SELL	$8.59 - $11.89 $214,028 - $296,251	-24,916 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$7.23 - $12.1 $180,142 - $301,483	24,916 New	24,916 $290,000

677K

Ticker HOOK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,654,500
Market Cap $98.7M
Description
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.